In addition, RFS duration of HCC patients was significantly associated with high expression of FUT1 (HR: 1.698, 95% CI: 1.067–2.701, P = 0.025) and B3GALT5 (HR: 2.082, 95% CI: 1.313–3.302, P = 0.002). The gene discussed is FUT1; the disease is hepatocellular carcinoma.